26 research outputs found
ΠΡΠ³ΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠ°ΠΊ ΠΌΠ΅ΡΠΎΠ΄ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΏΡΠΎΠ»ΠΎΠ½Π³ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΎΡΠΌ Π±ΠΈΠΎΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² (Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΠΏΡΠ³ΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Π³ΡΠ°Π½ΡΠ»ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠ΅ΡΡΠΈΠΌΡΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ°)
By now the pegylation of biologically active molecules including proteins with an inert hydrophilic polymer polyethylene glycol (PEG) is an important area in the new generation of prolonged-action pharmaceutical preparations. The conjugated molecules usually have an improved pharmacokinetic profile, including reduced renal clearance, additional protection from the proteolytic enzymes and reduced immunogenicity, thus preserving the in vivo activity of the native preparation in the human body for a longer time. This review is focused on the example of the pegylation of recombinant human granulocyte colony-stimulating factor (G-CSF) and gives the opportunity to have a look at different ways of pegylation and the mechanism of this reaction. Besides, the review describes the different types of reactive PEG for the specific conjugation to biological molecules and benefits and disadvantages of these reagents.Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠ³ΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ», Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π±Π΅Π»ΠΊΠΎΠ², Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΠ½Π΅ΡΡΠ½ΠΎΠ³ΠΎ Π³ΠΈΠ΄ΡΠΎΡΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ° ΠΏΠΎΠ»ΠΈΡΡΠΈΠ»Π΅Π½Π³Π»ΠΈΠΊΠΎΠ»Ρ (ΠΠΠ) ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΡΠΎΠ±ΠΎΠΉ Π²Π°ΠΆΠ½ΠΎΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ Π² ΡΠΎΠ·Π΄Π°Π½ΠΈΠΈ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΡΠΎΠ»ΠΎΠ½Π³ΠΈΡΠΎΠ²Π°Π½-Π½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ. ΠΠΎΠ½ΡΡΠ³ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ»Ρ, ΠΊΠ°ΠΊ ΠΏΡΠ°Π²ΠΈΠ»ΠΎ, ΠΈΠΌΠ΅ΡΡ ΡΠ»ΡΡΡΠ΅Π½Π½ΡΠΉ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΊΠΈΠ½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΡΠΎΡΠΈΠ»Ρ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΏΠΎΠ½ΠΈΠΆΠ΅Π½Π½ΡΠΉ ΠΏΠΎΡΠ΅ΡΠ½ΡΠΉ ΠΊΠ»ΠΈΡΠ΅Π½Ρ, Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ Π·Π°ΡΠΈΡΡ ΠΎΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΡΠΎΡΠ΅ΠΎ-Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠ² ΠΈ Π½ΠΈΠ·ΠΊΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΠΎΡΡΡ, ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠΎΡ
ΡΠ°Π½ΠΈΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ in vivo Π½Π°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π² ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΠΊΠΎΠΌ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π΅ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ. ΠΠ°Π½Π½ΡΠΉ ΠΎΠ±Π·ΠΎΡ Π΄Π°Π΅Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΎΠ·Π½Π°ΠΊΠΎΠΌΠΈΡΡΡΡ Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ°ΠΌΠΈ ΠΏΡΠ³ΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π±ΠΈΠΎΡΠ°ΡΠΌΠ°ΡΠ΅Π²-ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ», ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌΠΈ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΊΠΎΠ½ΡΡΠ³Π°ΡΠΎΠ² Ρ ΠΠΠ ΠΈ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅Ρ, ΠΊΠ°ΠΊ ΠΏΡΠΈΠΌΠ΅Ρ, ΠΏΡΠ³ΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π³ΡΠ°Π½ΡΠ»ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠ΅ΡΡΠΈΠΌΡΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° (ΡΡΠ-ΠΠ‘Π€). Π’Π°ΠΊΠΆΠ΅ Π² ΠΎΠ±Π·ΠΎΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ Π²ΠΈΠ΄Ρ ΠΌΠΎΠ΄ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΠΠ-ΡΠ΅Π°Π³Π΅Π½ΡΠΎΠ² Π΄Π»Ρ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΏΡΠΈΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ ΠΊ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΌΠΎΠ»Π΅ΠΊΡΠ»Π°ΠΌ ΠΈ ΠΎΠ±ΡΡΠΆΠ΄Π°ΡΡΡΡ ΠΈΡ
ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ
Thermodynamic model of hardness: Particular case of boron-rich solids
A number of successful theoretical models of hardness have been developed
recently. A thermodynamic model of hardness, which supposes the intrinsic
character of correlation between hardness and thermodynamic properties of
solids, allows one to predict hardness of known or even hypothetical solids
from the data on Gibbs energy of atomization of the elements, which implicitly
determine the energy density per chemical bonding. The only structural data
needed is the coordination number of the atoms in a lattice. Using this
approach, the hardness of known and hypothetical polymorphs of pure boron and a
number of boron-rich solids has been calculated. The thermodynamic
interpretation of the bonding energy allows one to predict the hardness as a
function of thermodynamic parameters. In particular, the excellent agreement
between experimental and calculated values has been observed not only for the
room- temperature values of the Vickers hardness of stoichiometric compounds,
but also for its temperature and concentration dependencies
The preparation of Ξ±-ALB12 and ALMGB14 samples and an investigation of their electrothermal properties
Pegylation, as method of production prolonged forms of biopharmaceutical drugs (pegylated granulocyte colony-stimulating factor as case of study)
By now the pegylation of biologically active molecules including proteins with an inert hydrophilic polymer polyethylene glycol (PEG) is an important area in the new generation of prolonged-action pharmaceutical preparations. The conjugated molecules usually have an improved pharmacokinetic profile, including reduced renal clearance, additional protection from the proteolytic enzymes and reduced immunogenicity, thus preserving the in vivo activity of the native preparation in the human body for a longer time. This review is focused on the example of the pegylation of recombinant human granulocyte colony-stimulating factor (G-CSF) and gives the opportunity to have a look at different ways of pegylation and the mechanism of this reaction. Besides, the review describes the different types of reactive PEG for the specific conjugation to biological molecules and benefits and disadvantages of these reagents